Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Responsible sourcing and manufacturing: Growing towards a sustainable future with Lonza
In response to the establishment of environmental impact targets by the pharmaceutical industry, Lonza promotes responsible…
Intra-Cellular Therapies acquisition will expand J&J’s presence in neurology space, says…
GlobalData forecasts that, as a therapy for schizophrenia, Caplyta could drive sales of approximately $229 million by 2033 in the…
Strengthening our presence within APAC through increased penetration is a key focus
Aanchal Tomar, Executive Director, Asia Pacific, Lonza Capsules & Health Ingredients speaks about Lonza Capsules & Health…
India’s life sciences sector: A vision for budget FY2025
Focus on enabling MSME business, expanding PLI scheme and research-linked incentives to foster API innovation and tax incentives…
CDSCO approves AstraZeneca’s anti-complement medicine Eculizumab
Eculizumab is approved in India to manage two rare diseases- Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Hemolytic…
Sun Pharma subsidiary Taro acquires Antibe Therapeutics
Antibe Therapeutics is a clinical-stage biotechnological company based in Ontario, Canada
DFE Pharma appoints Sven Abend as new CEO
Abend brings 25 years of global business leadership experience, with a track record of driving customer-centric strategies and…
Pharma Leadership and Innovation Conclave 2025 | 21st February 2025
21st February 2025 | Hilton, Mumbai International Airport
Pharmapack outlines pharma trends 2025, highlights market optimism despite uncertainty
Biologic approvals, drug delivery advancements, GLP-1 generics and the long-sought funding return to drive a record year in 2025,…
Alembic Pharma gets USFDA final approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3…
Brexpiprazole is an atypical antipsychotic used as an adjunctive therapy to antidepressants for the treatment of major depressive…